CARDIAC PROTECTIVE INOTROPIC THERAPY – OPPORTUNITIES AND PROSPECTIVE OF USING LEVOSIMENDAN IN CARDIAC SURGERY
Abstract Pharmacological support of the circulation remains to be a corner stone when managing patients with myocardial dysfunction. The article reviews the current theoretical and practical aspects of using levosimendan in cardiac surgery as an inotropic medication with the unique action mechanism...
Main Authors: | V. V. Pasyuga, V. V. Lomivorotov, A. A. Eremenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
New Terra Publishing House
2018-01-01
|
Series: | Вестник анестезиологии и реаниматологии |
Subjects: | |
Online Access: | https://www.vair-journal.com/jour/article/view/90 |
Similar Items
-
Safety and effectiveness of physical training in inotrop-dependent patients with compensation for chronic heart failure at the level of the III-IV functional class
by: Mariia A. Bortsova, et al.
Published: (2019-09-01) -
Современные и потенциальные возможности применения левосимендана в лечении сердечной недостаточности и септического шока: обзор литературы
by: Vladimir A. Boboshko, et al.
Published: (2023-07-01) -
Preoperative Prevention of Heart Failure in Noncardiac Surgery
by: V. V. Likhvantsev, et al.
Published: (2016-07-01) -
Pleiotropic effects of levosimendan on the heart and other organs
by: V. V. Lomivorotov, et al.
Published: (2017-07-01) -
PREVENTION OF HEART FAILURE IN NON-CARDIAC SURGERY WITH THE LOWER EJECTION FRACTION OF LEFT VENTRICULAR: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION? (randomized multi-centered trial)
by: V. V. Likhvantsev, et al.
Published: (2018-01-01)